Results 221 to 230 of about 25,775 (238)
Some of the next articles are maybe not open access.
Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review
Toxins, 2020Adrien Joseph +2 more
exaly
Advances in Renal Replacement Therapy, 2003
Raymond Camille Vanholder +1 more
openaire +1 more source
Raymond Camille Vanholder +1 more
openaire +1 more source
Journal of nephrology, 2001
Clinical signs and symptoms of end-stage renal failure patients are at least in part related to the accumulation of uremic retention solutes and uremic toxins. This article describes abnormalities caused by asymmetric dimethylarginine, advanced glycation end products, advanced lipoxidation end products, advanced oxidation protein products, homocysteine
openaire +1 more source
Clinical signs and symptoms of end-stage renal failure patients are at least in part related to the accumulation of uremic retention solutes and uremic toxins. This article describes abnormalities caused by asymmetric dimethylarginine, advanced glycation end products, advanced lipoxidation end products, advanced oxidation protein products, homocysteine
openaire +1 more source
Eculizumab in Severe Shiga-Toxin–Associated HUS
New England Journal of Medicine, 2011Michal Malina +2 more
exaly

